Text Size:AAA

人 COMP 蛋白 (His 標籤)

產品資料評論實驗方法
反應性: Human  
應用 : ELISA  
    10173-RP01-400
    10173-RP01-200
    10173-RP01-100
    400 µg 
    200 µg 
    100 µg 
    Add to Cart
    反應性: Human  
    應用 : ELISA  
      10173-MM02-50
      10173-MM02-100
      10173-MM02-1
      50 µg 
      100 µg 
      1 mg 
      Add to Cart
      反應性: Human  
      應用 : ELISA  
        10173-RP03-50
        10173-RP03-200
        10173-RP03-100
        50 µg 
        200 µg 
        100 µg 
        Add to Cart

        COMP Recombinant ProteinRelated Products

        Related Products

        Featured Reagent Products

        COMP protein 研究背景

        Cartilage Oligomeric Matrix Protein (COMP), also referred to as Thrombospondin-5, is a non-collagenous extracellular matrix (ECM) protein and belongs to the subgroup B of the thrombospondin protein family. This protein is expressed primarily in cartilage, ligament, and tendon, and binds to other ECM proteins such as collagen I, II and IX with high affinities depending on the divalent cations Zn2+ or Ni2+. COMP is a secreted glycoprotein that is important for growth plate organization and function. It is suggested to play a role in cell growth and development, and recent studies have revealed the possible mechanism that it protects cells against death by elevating members of the IAP (inhibitor of apoptosis protein) family of survival proteins. Mutations in COMP cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1), and up-regulated expression of COMP are observed in rheumatoid arthritis and certain carcinomas.

         COMP protein 參考資料
      • Posey KL, et al. (2004) Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol. 36(6): 1005-12.
      • Chen FH, et al. (2005) Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem. 282(34): 24591-8.
      • Posey KL, et al. (2008) The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets. 9(10): 869-77.
      • Tan K, et al. (2009) The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J. 23(8): 2490-501.
      • 請注意:所有產品都是“僅用於科研,而不能用於診斷或治療用途”